Prosecution Insights
Last updated: November 04, 2026

Aphios Corporation

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Aphios Corporation is managing 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units. The busiest examiner for the portfolio is PACKARD, BENJAMIN J, who is responsible for 1 busiest examiner pending action. The presence of 2 distinct examiners and 2 distinct art units for 2 pending office actions indicates that each active case is being reviewed by a different individual in a different technical group.

For a company in the Biotechnology & Pharmaceuticals sector, this structure shows a distributed technical scope. The busiest examiner, PACKARD, BENJAMIN J, handles 1 of the pending actions, while the total pending office actions for the company is 2. This distribution requires the company to manage different examiner styles and different art unit standards simultaneously. This approach provides diversity in examiner perspective and technical oversight, which can be beneficial for a portfolio with varied technical applications, though it requires more coordination than a centralized prosecution strategy.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
0
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PACKARD, BENJAMIN J 1 67.0% +15.3%
SIMMONS, CHRIS E 1 34.1% +19.8%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17311633 METHODS AND PRODUCTS FOR TREATING FOLIC ACID DEFICIENCY AND MORNING SICKNESS SIMMONS, CHRIS E 4d overdue
18634819 Methods For and Products From Encapsulation of Drugs in Nanoparticles in a Microgravity Environment PACKARD, BENJAMIN J —

Top Art Units

Art UnitApps
1612 1
1622 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18634819 Methods For and Products From Encapsulation of Drugs in Nanoparticles in a Microgravity Environment PACKARD, BENJAMIN J 1612 §103 Final Rejection — Pending Apr 12, 2024
17311633 METHODS AND PRODUCTS FOR TREATING FOLIC ACID DEFICIENCY AND MORNING SICKNESS SIMMONS, CHRIS E 1622 §103 Final Rejection 4d overdue Pending Jun 07, 2021

Managing Aphios Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Aphios Corporation have?

Aphios Corporation has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Aphios Corporation applications?

Benjamin J Packard has the most, with 1 of Aphios Corporation's pending office actions.

What technology area are Aphios Corporation's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month